Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 6, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Catalytic Triads Unlocked – Chemists Discover New Tool to Catalyse Enzymatic Reactions

A new therapeutic target for stomach cancer discovered

AIIMS Delhi Scientist (Non-Medical) & Research Fellow Recruitment

Catalytic Triads Unlocked – Chemists Discover New Tool to Catalyse Enzymatic Reactions
  • BiotechToday
  • World

Catalytic Triads Unlocked – Chemists Discover New Tool to Catalyse Enzymatic Reactions

bioxone December 17, 2020December 16, 2020

Sumedha Guha, Techno India University

Every enzyme family has a set of amino acids that are highly conserved in that specific enzyme family. Better known as catalytic triads, these are a set of three amino acid residues found in the active site of the enzymes which serve as a signature of the type of chemistry the enzyme can do.

Professor Francesca Paradisi and Dr. Martina Contente of the University of Nottingham and the University of Bern in their recent paper published in Nature Catalysis have elaborated on their groundbreaking work in expanding the synthetic capability of an acyltransferase variant found in Mycobacterium smegmatis. This enables them to yield a biocatalyst which can efficiently catalyze the formation of thioesters and tertiary amides in water. The use of the mutant variant of this enzyme can be utilized in the preparation of challenging chemical compounds, metabolites that are vital to many of the biological processes in the body and even for large scale drug production in the pharmaceutical industry.

This alteration was brought about by a strategic change in the Ser/Cys residues of the catalytic triads. Previously it was thought that doing this would cause a loss of activity of the enzyme but it has been found that such is not the case when the biocatalyst is used in a synthetic direction. Essential chemical molecules can now be made under mild conditions, which can be scaled up and replicated industrially for use in a wide range of commercial products.

Furthermore, two factors make this new one-step reaction in the enzyme a highly sustainable and low-cost procedure. These are – the high substrate to catalyst ratio and the cofactor independence. This renders the reaction as a viable tool that can be successfully applied to molecular reactions like the synthesis of acetyl coenzyme A as well as other structurally simpler analogues.

Also read:Nuclei of each muscle fiber differ in terms of gene activity

Source: https://scitechdaily.com/breaking-the-rules-of-chemistry-unlocks-new-reaction-with-applications-from-creating-new-drugs-to-food-production/

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged biocatalysts catalysts drug development Enzyme enzymology kinetics pharmaceuticals

One thought on “Catalytic Triads Unlocked – Chemists Discover New Tool to Catalyse Enzymatic Reactions”

  1. Pingback: Gut Microbiota In Psychological Stabilization - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

AIIMS Delhi Scientist (Non-Medical) & Research Fellow Recruitment

bioxone December 17, 2020

-Shristi Sharma, Team bioXone AIIMS Delhi Mol Bio & Life Science Research Recruitment. Scientist B (Non Medical) & Senior Research Fellow Jobs for PhD/MSc Life Science/Molecular Biology applicants. Interested and eligible applicants can check out all of the details on the same below: View Notification  Name of the Project: “SARCOPENIA IN CHRONIC PANCREATITIS: EPIDEMIOLOGY, DIAGNOSIS […]

Related Post

  • BiotechToday
  • World

Advancing photosynthesis to give better yield!

BioTech Today August 18, 2021August 17, 2021

Soumya Shraddhya Paul, Amity University, Noida Farmers would need to cultivate 50% more food on a limited quantity of arable land by 2050 to feed a predicted 9 billion people. As a result, plant scientists are racing against the clock to improve photosynthesis to design crops with better yields. Researchers are attempting to incorporate components […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Is the pandemic interfering with the treatment for other diseases?

bioxone October 19, 2020October 19, 2020

Camelia Bhattacharyya, Amity University Kolkata The pandemic, that is, the COVID-19 pandemic hit the world all of a sudden, changing infection rates or rather increasing it every day without leaving the world to think of the ways to fight with the unknown enemy, the virus. This created a lot of panic at the beginning of […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

CRISPR/Cas9 can cure Sickle Cell Disease in Stem Cells

bioxone October 16, 2020October 15, 2020

Sashreek Ganguli, Amity University Kolkata Sickle cell disease (SCD) is a set of blood disorders inherited from parents. It is a genetic disorder caused due to A-to-T base mutation within codon 6 of the HBB/Beta-globin gene (which is a part of haemoglobin A/ HgbA) responsible for the glutamic acid to valine substitution. It affects the […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy